Stay informed with the latest updates on coronavirus (COVID-19). Find out more >>

2023 updates

  • March 2023

    Fiasp and Fiasp FlexTouch to continue on the Pharmaceutical Benefit Scheme (PBS) for people living with type 1 diabetes for a further 6 months. 

    A statement from Diabetes Australia 17 March 2023

    Medtronic insulin pumps - product defect correction for the battery cap: For all people using a MiniMed™ 600 series and MiniMed™ 700 series insulin pump models, including MiniMed™ 640G, MiniMed™ 670G, MiniMed™ 700, MiniMed™ , MiniMed™ 770G, and MiniMed™ 780G should have received an email or letter from Medtronic advising them to check their battery cap and metal contact on their pump to see if they are damaged. See the complete recall notice. Please contact Medtronic Technical support on 1800 777 808 for further information and assistance. 

    January 2023

    School Action and Management Plans (Plan) for 2023

    All children/students with type 1 diabetes attending early childhood settings, primary or secondary schools in Victoria need to have a current Diabetes Action and Management plan in place to ensure that their diabetes care needs are met. These management have been developed by Diabetes Victoria, The Royal Children’s Hospital (RCH) and Monash Children’s Hospital, are based on current best practice paediatric guidelines and are reviewed yearly. 

    Visit the school page for further information  

    Last updated March 2023